Skip to main content

U.S. Physical Therapy, Inc.

corporate_fare Company Profile

U.S. Physical Therapy, Inc.

USPH·NYSE·Industrial Applications And Services·CIK 0000885978

U.S. Physical Therapy, Inc. operates through its subsidiaries, providing physical and industrial injury prevention services. The company's business is divided into two reportable segments. The physical therapy operations segment includes clinics and home-care practices offering physical, speech, and occupational therapy. These services address pre- and post-operative care, various orthopedic-related disorders, sports injuries, and rehabilitation for injured workers. The industrial injury prevention services (IIP) segment provides onsite services for client employees, focusing on injury prevention and rehabilitation, performance optimization, post-offer employment testing, functional capacity evaluations, and ergonomic assessments. The majority of IIP services are contracted with and paid for directly by employers, including a number of Fortune 500 companies, and are delivered by industrial sports medicine professionals with specialized musculoskeletal training. The company was re-incorporated in April 1992 in Nevada and has operating subsidiaries in various states structured as limited partnerships, limited liability companies, and wholly-owned corporations. Over the last three years, the company completed several acquisitions, including a 60% interest in the July 2025 Acquisition, a 40%* interest in the April 2025 Acquisition, a 65% interest in the February 2025 Acquisition, a 75% interest in the November 2024 Acquisition, a 50% interest in the October 2024 Acquisition, a 70% interest in the August 2024 Acquisition, a 50% interest in the March 2024 Acquisition, a 70% interest in the September 2023 Acquisition 1, a 70% interest in the September 2023 Acquisition 2, and a 70% interest in the July 2023 Acquisition.

U.S. Physical Therapy, Inc. (NYSE:USPH) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 19 items for USPH at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-05, rated 7/10. Across its 19 most recent items scored 7 or higher, the top rating is 8/10, with 8 rated 8 or above. Recent SEC coverage for USPH spans 8-K, 10-Q, DEF 14A, 10-K.

Recent high-impact activity:

  • USPH Q3: Adjusted EPS Beats at $0.80, But Revenue Falls Short of $214.5M
  • US Physical Therapy Posts $1.04 Per-Share Q3 Loss
  • USPH Posts 8.5% Revenue Growth to $214M in Q2, Reaffirms Full-Year Outlook
  • USPH Q2 Revenue Rises 8.5% to $214M, Reaffirms Full-Year Outlook
  • U.S. Physical Therapy Expands with 12-Clinic Acquisition, Adds New State, $12M Revenue

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
780.99M
Net Income
39.58M
Diluted EPS
1.42
Op. Cash Flow
75.06M
Free Cash Flow
60.99M
Gross Profit
149.69M
Operating Income
86.68M
Cash & Equivalents
35.57M
Total Debt
162.46M
Debt / Equity
0.34×
Net Margin
5.1%
Shares Outstanding
15.18M sh
Source: 10-K · filed 2026-02-27 · accession 0001140361-26-007170

Short Interest & Short Volume

7.71 days to cover

FINRA reported short interest of 1,129,075 shares in USPH as of the October 30, 2026 settlement, a 5.5% decrease from the prior period — about 7.7 days to cover at its recent average daily volume. On November 20, 2026, 67.9% of USPH volume reported to FINRA trade-reporting facilities was marked short.

Short interest (bi-monthly positions)1,129,075 shares as of October 30, 2026
Change vs prior period▼ 5.5%
Days to cover7.71 at avg daily volume of 146,365
Daily short volume (FINRA facilities)67.9% of 45,450 shares on November 20, 2026
5-day average short volume58.8%

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

Browse all tickers starting with U →
$95.93
52-week range · as of 2026-08-06 $58.19 – $95.93
Market cap
$1.43B
Volume
209.7K (1.1× avg)
3-mo avg 199.1K
Live data · 2026-11-22 04:49 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed USPH - Latest Insights

USPH
Nov 04, 2026, 9:45 PM EST
Source: Reuters
Importance Score:
7
Price at Filing: $94.00
Real-time Price: $95.93 info
Change: +$1.93 (+2%) info
Market Cap: $1.432B info
USPH
Nov 04, 2026, 4:23 PM EST
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $89.18
Real-time Price: $95.93 info
Change: +$6.75 (+8%) info
Market Cap: $1.432B info
USPH
Aug 06, 2026, 4:10 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $76.46
Real-time Price: $95.93 info
Change: +$19.47 (+25%) info
Market Cap: $1.432B info
USPH
Aug 05, 2026, 4:25 PM EDT
Source: BusinessWire
Importance Score:
7
Price at Filing: $77.71
Real-time Price: $95.93 info
Change: +$18.22 (+23%) info
Market Cap: $1.432B info
USPH
Jul 06, 2026, 4:23 PM EDT
Source: Wiseek News
Importance Score:
7
Price at Filing: $73.38
Real-time Price: $95.93 info
Change: +$22.55 (+31%) info
Market Cap: $1.432B info
USPH
Jul 06, 2026, 4:22 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $73.38
Real-time Price: $95.93 info
Change: +$22.55 (+31%) info
Market Cap: $1.432B info
USPH
Jul 02, 2026, 7:30 AM EDT
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $71.31
Real-time Price: $95.93 info
Change: +$24.62 (+35%) info
Market Cap: $1.432B info
USPH
May 11, 2026, 5:13 PM EDT
Source: Wiseek News
Importance Score:
7
Price at Filing: $59.42
Real-time Price: $95.93 info
Change: +$36.51 (+61%) info
Market Cap: $1.432B info
USPH
May 08, 2026, 4:11 PM EDT
Source: Wiseek News
Importance Score:
8
Price at Filing: $59.29
Real-time Price: $95.93 info
Change: +$36.64 (+62%) info
Market Cap: $1.432B info
USPH
May 08, 2026, 4:06 PM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $59.29
Real-time Price: $95.93 info
Change: +$36.64 (+62%) info
Market Cap: $1.432B info
USPH
May 06, 2026, 4:30 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $70.57
Real-time Price: $95.93 info
Change: +$25.36 (+36%) info
Market Cap: $1.432B info
USPH
Apr 16, 2026, 6:24 AM EDT
Filing Type: DEF 14A
Importance Score:
7
Price at Filing: $77.93
Real-time Price: $95.93 info
Change: +$18.00 (+23%) info
Market Cap: $1.432B info
USPH
Apr 15, 2026, 4:19 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $76.67
Real-time Price: $95.93 info
Change: +$19.26 (+25%) info
Market Cap: $1.432B info
USPH
Mar 13, 2026, 4:07 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $76.83
Real-time Price: $95.93 info
Change: +$19.10 (+25%) info
Market Cap: $1.432B info
USPH
Mar 03, 2026, 4:43 PM EST
Source: Wiseek News
Importance Score:
8
Price at Filing: $82.50
Real-time Price: $95.93 info
Change: +$13.43 (+16%) info
Market Cap: $1.432B info
USPH
Feb 27, 2026, 5:09 PM EST
Filing Type: 10-K
Importance Score:
8
Price at Filing: $82.96
Real-time Price: $95.93 info
Change: +$12.97 (+16%) info
Market Cap: $1.432B info
USPH
Feb 26, 2026, 8:30 AM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $81.68
Real-time Price: $95.93 info
Change: +$14.25 (+17%) info
Market Cap: $1.432B info
USPH
Feb 04, 2026, 4:08 PM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $82.60
Real-time Price: $95.93 info
Change: +$13.33 (+16%) info
Market Cap: $1.432B info
USPH
Jan 07, 2026, 4:05 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $79.47
Real-time Price: $95.93 info
Change: +$16.46 (+21%) info
Market Cap: $1.432B info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets